ATE494891T1 - Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung - Google Patents

Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung

Info

Publication number
ATE494891T1
ATE494891T1 AT08787357T AT08787357T ATE494891T1 AT E494891 T1 ATE494891 T1 AT E494891T1 AT 08787357 T AT08787357 T AT 08787357T AT 08787357 T AT08787357 T AT 08787357T AT E494891 T1 ATE494891 T1 AT E494891T1
Authority
AT
Austria
Prior art keywords
treatment
inflammatory bowel
bowel disease
carbonylamino derivatives
carbonylamino
Prior art date
Application number
AT08787357T
Other languages
English (en)
Inventor
Lars Madsen
Palle Christophersen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE494891T1 publication Critical patent/ATE494891T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08787357T 2007-08-24 2008-08-21 Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung ATE494891T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95781107P 2007-08-24 2007-08-24
DKPA200701211 2007-08-24
PCT/EP2008/060910 WO2009027292A1 (en) 2007-08-24 2008-08-21 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders

Publications (1)

Publication Number Publication Date
ATE494891T1 true ATE494891T1 (de) 2011-01-15

Family

ID=39870538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08787357T ATE494891T1 (de) 2007-08-24 2008-08-21 Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung

Country Status (11)

Country Link
US (1) US8455549B2 (de)
EP (2) EP2322164A3 (de)
JP (1) JP2010536827A (de)
AT (1) ATE494891T1 (de)
DE (1) DE602008004563D1 (de)
DK (1) DK2192896T3 (de)
ES (1) ES2358564T3 (de)
HR (1) HRP20110189T1 (de)
PL (1) PL2192896T3 (de)
PT (1) PT2192896E (de)
WO (1) WO2009027292A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2742610A1 (en) 2008-11-10 2010-05-14 Jun Li Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
WO2016134353A1 (en) * 2015-02-20 2016-08-25 Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3532045A4 (de) * 2016-10-25 2020-07-22 Paracelsus Neuroscience LLC Verwendung von senicapoc zur behandlung von neuropathischem schmerz

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314060T1 (de) 1996-03-20 2006-01-15 Harvard College Triarylmethanverbindungen zur behandlung von krebs, aktinischer keratose und kaposisarkom
US5889038A (en) 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
US6288122B1 (en) 1999-02-23 2001-09-11 Icagen, Inc. Gardos channel antagonists
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US6803375B1 (en) 2000-01-06 2004-10-12 The Regents Of The University Of California Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
EP2292595A1 (de) 2002-01-04 2011-03-09 NeuroSearch AS Kaliumkanal-Modulatoren
US7129618B2 (en) * 2003-03-31 2006-10-31 Canon Kabushiki Kaisha Control apparatus capable of low-speed driving of vibration type driving apparatus, actuating apparatus using the control apparatus, control method capable of low-speed driving of vibration type driving apparatus, and storage medium storing program including program codes capable of realizing the control method
GB0414272D0 (en) * 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
US20070185209A1 (en) * 2005-12-20 2007-08-09 Icagen, Inc. Treatment methods using triaryl methane compounds

Also Published As

Publication number Publication date
EP2192896B1 (de) 2011-01-12
US8455549B2 (en) 2013-06-04
DK2192896T3 (da) 2011-04-04
EP2192896A1 (de) 2010-06-09
JP2010536827A (ja) 2010-12-02
EP2322164A3 (de) 2011-12-07
PT2192896E (pt) 2011-04-04
DE602008004563D1 (de) 2011-02-24
PL2192896T3 (pl) 2011-06-30
HRP20110189T1 (hr) 2011-04-30
WO2009027292A1 (en) 2009-03-05
US20110124735A1 (en) 2011-05-26
ES2358564T3 (es) 2011-05-11
EP2322164A2 (de) 2011-05-18

Similar Documents

Publication Publication Date Title
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
EP2182983A4 (de) Behandlung von amyloidogenen erkrankungen
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
ATE557021T1 (de) Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens
EA201370208A1 (ru) Формы рифаксимина и их применение
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
EP3769718C0 (de) Vorrichtung zur behandlung von darmerkrankungen
EP2411004A4 (de) Verwendung von andrographolidverbindungen zur behandlung von entzündungen und atemwegserkrankungen
ME00582A (en) Tricyclic compound and pharmaceutical use thereof
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
ATE537178T1 (de) Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten
ATE484279T1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
EP1924269A4 (de) Vegetationswasser-zusammensetzung zur behandlung von entzündlichen hautkrankheiten
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EA201200855A1 (ru) Модуляторы crth2
ATE524456T1 (de) Zur behandlung von erkrankungen, die auf eine modulation des serotonin-5-ht6-rezeptors ansprechen, geeignete chinolinverbindung
ATE494891T1 (de) Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2192896

Country of ref document: EP